ORLANDO, Fla., Nov. 4, 2011 (GLOBE NEWSWIRE) -- A targeted, nanoparticle gelatin-based clot-busting treatment dissolved significantly more blood clots than a currently used drug in an animal study of acute coronary syndrome presented at the American Heart Association's Scientific Sessions 2011.
